Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Amili Probiotic Pills

Research Leaders

5 sponsors active, led by Singapore Institute of Technology

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05752266Not ApplicableCompletedPrimary

Effect of Probiotics on Amino Acid Absorption

NCT04917913Not ApplicableUnknown

Efficacy of a Digestive Enzyme Blend

NCT04282096Not ApplicableCompletedPrimary

Nutritional Caracterisation of Micellar Casein

Showing all 3 trials

Research Network

Common Treatments

  • Amili Probiotic Pills1
  • Digestive Enzyme Blend1
  • Native And Non Native Casein1

Active Sponsors

  • Singapore Institute of Technology1
  • Deerland Enzymes1
  • Ingredia S.A.1
  • AMILI Pte. Ltd.1
  • Kennesaw State University1

Top Investigators

Related Conditions

  • Gastrointestinal Microbiome1
  • Digestive Health1
  • Indigestion1
  • Satiety1
  • Fat Digestion1

Activity Timeline